MVision AI 🇫🇮
AI radiotherapy workflow platform: auto-contouring, synthetic imaging and dose prediction. Helsinki.
About MVision AI
MVision AI provides AI-based software that automates repetitive steps in radiotherapy treatment planning and supports consistent clinical workflows. Its modular platform includes automated contouring, synthetic imaging, dose prediction, and contour propagation, and integrates with existing treatment planning systems.
MVision AI is a Finland-based company founded in 2017, now around 55 people. FundFinder classes it as AI & ML.
Founded by Jarkko Niemelä (Co-Founder; previously Freelance musician and composer, STUK - Säteilyturvakeskus; University of Jyväskylä), Saad Ullah Akram (CTO and co-founder; previously Tellus; KTH Royal Institute of Technology), Mahmudul Hasan (Chief Executive Officer; repeat founder; previously Amtech Power Software, Atos; University of Oxford), Heikki Arponen (Senior Research Scientist, Co-founder; previously Freelancer, Helsinki Collegium for Advanced Studies; University of Helsinki).
Its investors also appear on FundFinder's most-active lists for Seed · AI (93 funds), Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · Jun 2025
- Voima Ventures — Helsinki deep tech VC with an office in Stockholm. · cheques £170k – £2.5M